Methods for synthesizing quinolinone compounds

Details for Australian Patent Application No. 2004288709 (hide)

Owner Novartis Vaccines and Diagnostics, Inc.

Inventors Shang, Xiao; Okhamafe, Augustus O.; Machajewski, Timothy D.; Harwood, Eric; Cai, Shaopei; Ryckman, David; Tesconi, Marc S.; Zhu, Shuguang; Chou, Joyce

Agent FB Rice

Pub. Number AU-B-2004288709

PCT Pub. Number WO2005/046590

Priority 60/546,017 19.02.04 US; 60/526,425 02.12.03 US; 60/526,426 02.12.03 US; 60/517,915 07.11.03 US

Filing date 5 November 2004

Wipo publication date 26 May 2005

Acceptance publication date 6 January 2011

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4375 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/046590 Priority application(s): WO2005/046590

23 April 2009 Alteration of Name

  The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc.

6 January 2011 Application Accepted

  Published as AU-B-2004288709

12 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004288711-Electrically activated alteration of body tissue stiffness for breathing disorders

2004288704-Fluid verification system and method for infusions